Open access
Sep 2026
Influencing Factors of Prognosis in Adjuvant Trastuzumab Therapy for HER2-Positive Breast Cancer.
ObjectiveThis study aims to conduct a comprehensive, multidimensional evaluation of how clinical and pathological factors influence invasive disease-free survival (IDFS) and cancer-specific survival (CSS) in patients with human epidermal growth factor receptor 2 (ERBB2/HER2) positive breast cancer receiving adjuvant tr...
Lei Guan, Lu Wang, Chen-Ying Liu et al.
· International Journal of Sur... · 0 citations